The biometric sensor developer has now raised $13.5m in equity, after a series C round that included a second investment by electronics retailer Best Buy.
Month: June 2014
PowerVision widens gaze to close $30m series D
The intraocular lens developer has now raised more than $90m, after completing a series D round that included Johnson & Johnson and Medtronic.
Lupin to invest up to $1bn in European acquisitions
The India-based drug developer will seek businesses specialising in generic products as it looks to expand its reach in Europe.
UCloud to float in US after $50m round
Bertelsmann and Legend Holdings co-led the cloud infrastructure company’s $50m series B, which could be a prelude to an initial public offering in the US.
Buzzfeed reportedly enters talks for $200m series E
The online media company is said to have begun talks for a $200m venture round that could meet its $1bn+ valuation.
CounterTack secures $20m series B
The Siemens-backed cloud security software producer has closed its series B after an investment from Razor’s Edge, and has now raised about $30m.
Picooc scales $21m round
Tencent and JD.com have invested in an early-stage round for smart scale manufacturer Picooc.
GSK to profit from Convergence as it eyes IPO
Convergence Pharmaceuticals, spun out of GlaxoSmithKline, which still holds an 18% stake, is considering both London and New York for its initial public offering.
Corporates travel to Bull City for $26m fund
The venture capital firm has closed its oversubscribed third fund with commitments from Cisco, Red Hat and Capitol Broadcasting among others.
True North points way to $22m series A
Pharmaceutical companies including Baxter, Biogen Idec and GlaxoSmithKline, through its SR One subsidiary, all backed the round, which also included funds from True Norths’ parent company iPierian.
Kony mobilises $50m in Softbank-led series E
The mobile app development platform has now raised $108m in total after Southbank joined another telecommunications company, Telstra, as an investor.
Medisun shines on Cardio3 Biosciences
The Chinese company has invested $34m in Cardio3 in addition to forming a joint venture to commercialise a heart failure indicator.
American Family to invest $50m through corporate venturing
The insurance company will provide the funding over the next for to five years, and will seek out startups engaged in complementary sectors.
CTQuan to crowd in $100m for venture fund
The crowdfunding service, which has just secured $4m from angel investors, will seek to invest in foreign startups out of a corporate venturing fund that could reach $100m.